Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | April 07, 2023 09:06am

Gainers

  • CNS Pharma (NASDAQ:CNSP) stock rose 53.6% to $1.33 during Friday's pre-market session. The market value of their outstanding shares is at $1.7 million. The company's, Q4 earnings came out 4 days ago.
  • VistaGen Therapeutics (NASDAQ:VTGN) stock moved upwards by 19.81% to $0.16. The market value of their outstanding shares is at $34.8 million.
  • Aprea Therapeutics (NASDAQ:APRE) shares increased by 16.92% to $4.49. The market value of their outstanding shares is at $16.7 million.
  • LumiraDx (NASDAQ:LMDX) stock moved upwards by 16.36% to $0.64. The market value of their outstanding shares is at $203.3 million.
  • OncoCyte (NASDAQ:OCX) shares increased by 16.09% to $0.31. The company's market cap stands at $37.2 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Sonida Senior Living (NYSE:SNDA) shares rose 13.79% to $8.0. The company's market cap stands at $55.3 million.

Losers

  • Scilex Holding (NASDAQ:SCLX) shares declined by 16.2% to $10.39 during Friday's pre-market session. The market value of their outstanding shares is at $1.5 billion.
  • Vallon Pharmaceuticals (NASDAQ:VLON) shares decreased by 16.1% to $0.37. The company's market cap stands at $4.9 million.
  • BIMI Intl Medical (NASDAQ:BIMI) shares decreased by 9.63% to $0.51. The market value of their outstanding shares is at $1.9 million.
  • HCW Biologics (NASDAQ:HCWB) stock declined by 8.97% to $1.32. The company's market cap stands at $47.3 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock fell 8.45% to $0.4. The company's market cap stands at $6.2 million.
  • Eloxx Pharmaceuticals (NASDAQ:ELOX) stock decreased by 7.61% to $3.89. The market value of their outstanding shares is at $8.4 million. The company's, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: APRE BIMI CNSP ELOX HCWB LMDX OCX RNAZ SCLX SNDA VLON VTGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist